Conventional chemotherapies remain the mainstay of treatment for many malignancies.
Kidney complications of these therapies are not infrequent and may have serious …

In the last several decades, advancements in chemotherapy have improved the overall
survival of cancer patients. These agents, however, are associated with adverse effects …

Severe adverse systemic drug events occur commonly as a result of treatment of cancer
patients. Nephrotoxicity of chemotherapeutic agents remains a significant complication …

Despite dramatic improvements in patient survival and drug tolerability, nephrotoxicity
remains an important complication of chemotherapy. Adverse renal effects occur because of …

New anticancer medications are rapidly entering the clinical arena offering patients with
previously resistant cancers the promise of more effective therapies capable of extending …

The relation that connects cancer and renal damage is bidirectional and this renal damage
worsens quality of life and increases morbidity in high-complexity patients such as patients …

Anticancer drug nephrotoxicity is an important and increasing adverse drug event that limits
the efficacy of cancer treatment. The kidney is an important elimination pathway for many …

Anticancer drug-induced kidney disease is a problem commonly encountered by
nephrologists. The number of medications employed by oncologists causing acute and …

Several conventional chemotherapeutics have been associated with renal side effects
including kidney function deterioration, electrolyte disorders, tubular injury, glomerular …

Advances in cancer drug therapy have led to improvements in the outcomes of cancer
patients, as well as increasing numbers of patients undergoing anticancer chemotherapy …